Cargando…

Characterization of amino acid substitutions in feline coronavirus 3C-like protease from a cat with feline infectious peritonitis treated with a protease inhibitor

Feline infectious peritonitis (FIP) is a highly fatal disease caused by a virulent feline coronavirus in domestic and wild cats. We have previously reported the synthesis of potent coronavirus 3C-like protease (3CLpro) inhibitors and the efficacy of a protease inhibitor, GC376, in client-owned cats...

Descripción completa

Detalles Bibliográficos
Autores principales: Perera, Krishani Dinali, Rathnayake, Athri D., Liu, Hongwei, Pedersen, Niels C., Groutas, William C., Chang, Kyeong-Ok, Kim, Yunjeong
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Elsevier B.V. 2019
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6779346/
https://www.ncbi.nlm.nih.gov/pubmed/31585653
http://dx.doi.org/10.1016/j.vetmic.2019.108398
_version_ 1783456914349228032
author Perera, Krishani Dinali
Rathnayake, Athri D.
Liu, Hongwei
Pedersen, Niels C.
Groutas, William C.
Chang, Kyeong-Ok
Kim, Yunjeong
author_facet Perera, Krishani Dinali
Rathnayake, Athri D.
Liu, Hongwei
Pedersen, Niels C.
Groutas, William C.
Chang, Kyeong-Ok
Kim, Yunjeong
author_sort Perera, Krishani Dinali
collection PubMed
description Feline infectious peritonitis (FIP) is a highly fatal disease caused by a virulent feline coronavirus in domestic and wild cats. We have previously reported the synthesis of potent coronavirus 3C-like protease (3CLpro) inhibitors and the efficacy of a protease inhibitor, GC376, in client-owned cats with FIP. In this study, we studied the effect of the amino acid changes in 3CLpro of feline coronavirus from a feline patient who received antiviral treatment for prolonged duration. We generated recombinant 3CLpro containing the identified amino acid changes (N25S, A252S or K260 N) and determined their susceptibility to protease inhibitors in the fluorescence resonance energy transfer assay. The assay showed that N25S in 3CLpro confers a small change (up to 1.68-fold increase in the 50% inhibitory concentration) in susceptibility to GC376, but other amino acid changes do not affect susceptibility. Modelling of 3CLpro carrying the amino acid changes was conducted to probe the structural basis for these findings. The results of this study may explain the observed absence of clinical resistance to the long-term antiviral treatment in the patients.
format Online
Article
Text
id pubmed-6779346
institution National Center for Biotechnology Information
language English
publishDate 2019
publisher Elsevier B.V.
record_format MEDLINE/PubMed
spelling pubmed-67793462020-04-02 Characterization of amino acid substitutions in feline coronavirus 3C-like protease from a cat with feline infectious peritonitis treated with a protease inhibitor Perera, Krishani Dinali Rathnayake, Athri D. Liu, Hongwei Pedersen, Niels C. Groutas, William C. Chang, Kyeong-Ok Kim, Yunjeong Vet Microbiol Article Feline infectious peritonitis (FIP) is a highly fatal disease caused by a virulent feline coronavirus in domestic and wild cats. We have previously reported the synthesis of potent coronavirus 3C-like protease (3CLpro) inhibitors and the efficacy of a protease inhibitor, GC376, in client-owned cats with FIP. In this study, we studied the effect of the amino acid changes in 3CLpro of feline coronavirus from a feline patient who received antiviral treatment for prolonged duration. We generated recombinant 3CLpro containing the identified amino acid changes (N25S, A252S or K260 N) and determined their susceptibility to protease inhibitors in the fluorescence resonance energy transfer assay. The assay showed that N25S in 3CLpro confers a small change (up to 1.68-fold increase in the 50% inhibitory concentration) in susceptibility to GC376, but other amino acid changes do not affect susceptibility. Modelling of 3CLpro carrying the amino acid changes was conducted to probe the structural basis for these findings. The results of this study may explain the observed absence of clinical resistance to the long-term antiviral treatment in the patients. Elsevier B.V. 2019-10 2019-08-23 /pmc/articles/PMC6779346/ /pubmed/31585653 http://dx.doi.org/10.1016/j.vetmic.2019.108398 Text en © 2019 Elsevier B.V. All rights reserved. Since January 2020 Elsevier has created a COVID-19 resource centre with free information in English and Mandarin on the novel coronavirus COVID-19. The COVID-19 resource centre is hosted on Elsevier Connect, the company's public news and information website. Elsevier hereby grants permission to make all its COVID-19-related research that is available on the COVID-19 resource centre - including this research content - immediately available in PubMed Central and other publicly funded repositories, such as the WHO COVID database with rights for unrestricted research re-use and analyses in any form or by any means with acknowledgement of the original source. These permissions are granted for free by Elsevier for as long as the COVID-19 resource centre remains active.
spellingShingle Article
Perera, Krishani Dinali
Rathnayake, Athri D.
Liu, Hongwei
Pedersen, Niels C.
Groutas, William C.
Chang, Kyeong-Ok
Kim, Yunjeong
Characterization of amino acid substitutions in feline coronavirus 3C-like protease from a cat with feline infectious peritonitis treated with a protease inhibitor
title Characterization of amino acid substitutions in feline coronavirus 3C-like protease from a cat with feline infectious peritonitis treated with a protease inhibitor
title_full Characterization of amino acid substitutions in feline coronavirus 3C-like protease from a cat with feline infectious peritonitis treated with a protease inhibitor
title_fullStr Characterization of amino acid substitutions in feline coronavirus 3C-like protease from a cat with feline infectious peritonitis treated with a protease inhibitor
title_full_unstemmed Characterization of amino acid substitutions in feline coronavirus 3C-like protease from a cat with feline infectious peritonitis treated with a protease inhibitor
title_short Characterization of amino acid substitutions in feline coronavirus 3C-like protease from a cat with feline infectious peritonitis treated with a protease inhibitor
title_sort characterization of amino acid substitutions in feline coronavirus 3c-like protease from a cat with feline infectious peritonitis treated with a protease inhibitor
topic Article
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6779346/
https://www.ncbi.nlm.nih.gov/pubmed/31585653
http://dx.doi.org/10.1016/j.vetmic.2019.108398
work_keys_str_mv AT pererakrishanidinali characterizationofaminoacidsubstitutionsinfelinecoronavirus3clikeproteasefromacatwithfelineinfectiousperitonitistreatedwithaproteaseinhibitor
AT rathnayakeathrid characterizationofaminoacidsubstitutionsinfelinecoronavirus3clikeproteasefromacatwithfelineinfectiousperitonitistreatedwithaproteaseinhibitor
AT liuhongwei characterizationofaminoacidsubstitutionsinfelinecoronavirus3clikeproteasefromacatwithfelineinfectiousperitonitistreatedwithaproteaseinhibitor
AT pedersennielsc characterizationofaminoacidsubstitutionsinfelinecoronavirus3clikeproteasefromacatwithfelineinfectiousperitonitistreatedwithaproteaseinhibitor
AT groutaswilliamc characterizationofaminoacidsubstitutionsinfelinecoronavirus3clikeproteasefromacatwithfelineinfectiousperitonitistreatedwithaproteaseinhibitor
AT changkyeongok characterizationofaminoacidsubstitutionsinfelinecoronavirus3clikeproteasefromacatwithfelineinfectiousperitonitistreatedwithaproteaseinhibitor
AT kimyunjeong characterizationofaminoacidsubstitutionsinfelinecoronavirus3clikeproteasefromacatwithfelineinfectiousperitonitistreatedwithaproteaseinhibitor